Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Hutchmed (China)
HCM
5
Lantheus
LNTH
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | -10.64%1.39B | -21.15%303.15M | -16.58%311.43M | -5.71%398.1M | 0.30%382.28M | -19.08%1.56B | -5.05%384.46M | -18.89%373.31M | -20.05%422.21M | -28.90%381.14M |
Operating revenue | -10.64%1.39B | -21.15%303.15M | -16.58%311.43M | -5.71%398.1M | 0.30%382.28M | -19.08%1.56B | -5.05%384.46M | -18.89%373.31M | -20.05%422.21M | -28.90%381.14M |
Cost of revenue | -7.56%1.1B | -24.82%233.49M | -15.48%245.45M | 1.05%317.94M | 10.19%307.92M | -15.94%1.2B | 23.70%310.59M | -17.69%290.41M | -22.70%314.64M | -31.98%279.46M |
Gross profit | -20.73%290.16M | -5.70%69.66M | -20.42%65.98M | -25.47%80.17M | -26.87%74.36M | -27.89%366.03M | -51.98%73.87M | -22.86%82.9M | -11.18%107.57M | -18.79%101.68M |
Operating expense | -0.62%481.13M | -18.70%112.55M | -11.55%109.53M | 13.73%127.17M | 19.84%131.88M | 0.73%484.13M | -11.53%138.44M | 21.63%123.83M | 2.06%111.82M | -2.40%110.05M |
Selling and administrative expenses | -0.63%312.96M | -25.84%70.35M | -14.97%69.43M | 19.61%84.82M | 30.84%88.36M | 6.70%314.96M | 47.75%94.86M | 13.11%81.65M | -10.26%70.92M | -15.34%67.53M |
-Selling and marketing expense | 6.24%238.56M | -25.75%52.51M | -9.87%51.86M | 34.62%66.29M | 44.33%67.91M | 4.21%224.55M | 55.41%70.72M | 7.51%57.54M | -15.01%49.24M | -19.59%47.05M |
-General and administrative expense | -17.71%74.4M | -26.10%17.84M | -27.12%17.57M | -14.50%18.53M | -0.14%20.45M | 13.44%90.41M | 29.12%24.15M | 29.17%24.11M | 2.81%21.67M | -3.64%20.48M |
Research and development costs | -2.19%114.58M | 1.10%29.99M | -5.36%27.67M | -1.31%27.34M | -3.16%29.58M | -3.30%117.15M | 5.94%29.66M | -1.31%29.24M | -9.29%27.71M | -7.41%30.55M |
Other operating expenses | 3.00%53.59M | -12.22%12.21M | -4.00%12.43M | 13.71%15.01M | 16.47%13.94M | -19.05%52.02M | --13.91M | --12.94M | --13.2M | --11.97M |
Operating profit | -61.69%-190.97M | 33.57%-42.89M | -6.41%-43.55M | -1,006.17%-47M | -587.77%-57.53M | -537.30%-118.11M | -2,339.06%-64.56M | -823.27%-40.93M | -136.81%-4.25M | -167.16%-8.36M |
Net non-operating interest income expense | -43.66%6.77M | -94.20%185K | -51.45%1.55M | -24.52%2.31M | 6.17%2.72M | 304.96%12.01M | 59.48%3.19M | 227.97%3.2M | 2,560.00%3.06M | 2,147.20%2.56M |
Non-operating interest income | -34.87%8.97M | -51.76%2.39M | -51.45%1.55M | -24.52%2.31M | ---- | 180.83%13.77M | 25.73%4.95M | 227.97%3.2M | --3.06M | ---- |
Non-operating interest expense | 25.03%2.2M | ---- | ---- | ---- | ---- | -9.08%1.76M | ---- | ---- | ---- | ---- |
Total other finance cost | ---- | ---- | ---- | ---- | -6.17%-2.72M | ---- | ---- | ---- | ---- | -2,147.20%-2.56M |
Other net income (expense) | 53.82%-73.91M | -15.87%-38.51M | 51.35%-18.84M | 102.77%2.23M | -154.31%-18.79M | -150.72%-160.02M | -115.13%-33.23M | 16.32%-38.73M | -3,972.34%-80.67M | -6,381.58%-7.39M |
Gain on sale of security | -6,650.00%-2.43M | ---- | ---- | ---- | ---- | 73.72%-36K | ---- | ---- | ---- | ---- |
Earnings from equity interest | 44.67%-77.69M | ---- | ---- | ---- | ---- | -119.65%-140.4M | ---- | ---- | ---- | ---- |
Special income (charges) | 135.31%6.89M | ---- | ---- | ---- | ---- | ---19.51M | ---- | ---- | ---- | ---- |
-Less:Impairment of capital assets | -86.92%3.39M | ---- | ---- | ---- | ---- | --25.88M | ---- | ---- | ---- | ---- |
-Gain on sale of property,plant,equipment | 61.53%10.28M | ---- | ---- | ---- | ---- | --6.36M | ---- | ---- | ---- | ---- |
Other non- operating income (expenses) | -871.43%-680K | -72.60%34.72M | 51.35%-18.84M | 102.77%2.23M | -154.31%-18.79M | -129.79%-70K | 160.68%126.72M | 16.32%-38.73M | -3,972.34%-80.67M | -6,381.58%-7.39M |
Income before tax | 3.01%-258.11M | 14.16%-81.21M | 20.43%-60.84M | 48.13%-42.46M | -457.82%-73.6M | -686.13%-266.12M | -487.79%-94.61M | -92.85%-76.46M | -946.04%-81.86M | -208.01%-13.19M |
Income tax | -98.36%684K | -99.93%49K | 101.41%189K | 101.40%117K | 111.40%329K | 2,914.45%41.72M | 11,467.81%66.39M | -405.50%-13.41M | -430.96%-8.37M | -238.00%-2.89M |
Net income | 15.93%-258.8M | 49.53%-81.26M | 3.20%-61.03M | 42.07%-42.58M | -617.26%-73.93M | -773.66%-307.84M | -937.93%-160.99M | -70.43%-63.05M | -1,128.31%-73.49M | -201.82%-10.31M |
Net income continuous Operations | 15.93%-258.8M | 49.53%-81.26M | 3.20%-61.03M | 42.07%-42.58M | -617.26%-73.93M | -773.66%-307.84M | -937.93%-160.99M | -70.43%-63.05M | -1,128.31%-73.49M | -201.82%-10.31M |
Minority interest income | ||||||||||
Net income attributable to the parent company | 15.93%-258.8M | 49.53%-81.26M | 3.20%-61.03M | 42.07%-42.58M | -617.26%-73.93M | -773.66%-307.84M | -937.93%-160.99M | -70.43%-63.05M | -1,128.31%-73.49M | -201.82%-10.31M |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | 15.93%-258.8M | 49.53%-81.26M | 3.20%-61.03M | 42.07%-42.58M | -617.26%-73.93M | -733.51%-307.84M | -861.84%-160.99M | -70.43%-63.05M | -1,558.19%-73.49M | -214.66%-10.31M |
Basic earnings per share | 18.36%-5.56 | 53.24%-1.66 | 4.32%-1.33 | 42.94%-0.93 | -604.35%-1.62 | -720.48%-6.81 | -944.12%-3.55 | -71.60%-1.39 | -1,458.33%-1.63 | -209.52%-0.23 |
Diluted earnings per share | 18.36%-5.56 | 53.24%-1.66 | 4.32%-1.33 | 42.94%-0.93 | -604.35%-1.62 | -720.48%-6.81 | -944.12%-3.55 | -71.60%-1.39 | -1,458.33%-1.63 | -209.52%-0.23 |
Dividend per share | ||||||||||
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- | -- | -- |